Related Experiment Videos
ATM and ataxia telangiectasia
1Department of Genetics and Tumor Cell Biology, St Jude Children's Research Hospital, 332 N.Lauderdale, Memphis, Tennessee 38105, USA. peter.mckinnon@stjude.org
EMBO Reports
|August 4, 2004
Summary
Ataxia telangiectasia (AT) is a rare neurodegenerative disease linked to DNA damage response defects. Understanding ATM kinase in AT offers insights into cancer and neurodegeneration.
Area of Science:
- Genetics and Molecular Biology
- Neurobiology
- Cancer Biology
Background:
- Ataxia telangiectasia (AT) presents with neurodegeneration, immune dysfunction, radiosensitivity, and cancer predisposition.
- Mutations in ATM (ataxia telangiectasia, mutated) are identified as the genetic cause of AT.
- ATM kinase is a critical regulator of the cellular response to DNA double-strand breaks.
Purpose of the Study:
- To elucidate the role of ATM kinase in the cellular response to DNA damage.
- To understand the fundamental processes underlying neurodegeneration and cancer through the study of AT.
Main Methods:
- Biochemical analysis of ATM kinase and its substrates.
- Investigating the cellular response pathways involving ATM.
Main Results:
- ATM kinase acts as a central hub in the DNA damage response pathway.
- ATM kinase substrates are involved in cancer prevention mechanisms.
Conclusions:
- Defects in DNA damage response, specifically involving ATM, cause AT.
- Studying AT provides crucial insights into the molecular mechanisms of cancer and neurodegeneration.